| Literature DB >> 35055565 |
Marta Mazur1, Artnora Ndokaj1, Beatrice Marasca1, Gian Luca Sfasciotti1, Roberto Marasca2, Maurizio Bossù1, Livia Ottolenghi1, Antonella Polimeni1.
Abstract
Germectomy is a procedure often required in patients at developmental age. It is defined as the surgical removal of the third molar at a very specific stage of development. The aim of this study was to systematically analyze the literature in terms of clinical indications for germectomy in patients at developmental age. Literature searches were performed using PubMed, Google Scholar, Cochrane Library and Scopus from 1952 to 30 June 2021. The study protocol was registered after the screening stage (PROSPERO CRD42021262949). The search strategy identified 3829 articles: 167 from PubMed, 2860 from Google Scholar, 799 from Cochrane Library and 3 from Scopus. Finally, eight full-text papers were included into the qualitative analysis. Based on the included studies, clinical indications for germectomy were mainly related to orthodontic causes, infectious and cariogenic causes and prophylaxis. Based on these results, it is not possible to present evidence-based clinical indications for germectomy in patients at developmental age. Clinical trials on this subject focused specifically on patients at developmental age are awaited.Entities:
Keywords: clinical indications; dentistry; germectomy; oral health; oral surgery; systematic review
Mesh:
Year: 2022 PMID: 35055565 PMCID: PMC8775662 DOI: 10.3390/ijerph19020740
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart of the search.
Study characteristics.
| Author | Year | Study Type | Population (Age and n) | Mean Age/Age Range and/or σ | Developmental Age Patients (Age and n) | Female % | Setting (University Clinic, Dental Clinic) | Intervention (Extraction) and n | Comparison-No Intervention (If Present, State: No Extraction or Other) and n | Clinical Indication to Extraction | Any Outcome, If Present | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adeyemo [ | 2008 | cohort | 15–92 | 33.74 ± 13.3 | 10–19 | 58% | University of Lagos, Nigeria | 506 surgical ex | 1257 no ex | 506 ex | caries n.34; pericoronitis n.28 | - | |
| Chiapasco [ | 1995 | cohort | 9–67 | Group A: 9–16 y | 9–16 | 53% | University of Milan, Italy | 254 surgical ex | orthodontic indication | Complications: Group A 9–16y 2.6%; B 17–24 y 2.8%; C >24 y 7.4% | |||
| D’Angeli [ | 2021 | cohort | 11–17 | 15.44 ± 2.06 y | 11–17 | 40% | Sapienza University of Rome, Italy | 46 surgical ex | orthodontic indication | Complications: 4.2%, no association among gender, Winter’s class, germ development | |||
| Monaco [ | 2016 | cohort | 12–20 | 15 | 49% | University of Bologna, Italy | 218 surgical ex | orthodontic indication | Delayed infection: 20 (9.2%), 16/20 Ganss Ratio < 0.5 | ||||
| Werkmeister [ | 2005 | case-control | 11–81 | 316 test, mean a:33.3; 300 control, mean a: 26.7 | test group: 25.3 %, control group 47% | University Hospital of Muster, Switzerland | 616 surgical ex | 316 ex with pathology | 300 ex without pathology | cysts, space abscess formation, mandibular fractures | The development of complications is influenced by position of the teeth “position scores” | ||
| Zhang [ | 2012 | cohort | 10–59 | Group A: 518 a:17 y Group B: 532 a: 39 y | 10–23 | Group A: 55.5% | Guangzhou Medical College, China | 1050 surgical ex | 518 < 23 y | 532 > 23 y | orthodontic i. | pathological lesions | Early removal of lower third molar reduce postoperative complications. Group A: 2.48% Group B: 10% |
| Harradine [ | 1998 | RCT | n = 164 | 14 y | 55% | 44 surgical ex | 44 ex | 33 no ex | incisor crowding | No significant difference | |||
| Cassetta [ | 2017 | cohort | n = 14 | Group A: 12.9 ± 0.5 Group B: 12.6 ± 0.5 | all | Group A: 50%; Group B: 20% | Sapienza University of Rome, Italy | brass wire ligature with germectomy | brass wire ligature without germectomy | LM2 uprighting | Full eruption LM2 in 5.7 months in both groups; LM3 germ extraction not recommended | ||
n = number, σ = standard deviation; % = percentage, RCT = randomized controlled trial; y = years; a = age; i = indication; LM2 = lower second molar; LM3 = lower third molar.
Jadad scale for reporting randomized controlled trials.
| Jadad Scale for Reporting Randomized Controlled Trials | |
|---|---|
| Author | Harradine 1998 [ |
|
Is the study described as randomized? | 1 |
|
Is the study described as double blind? | 0 |
|
Is there a description of withdrawals and dropouts? | 1 |
|
The method of randomisation is appropriate? | 1 |
|
The method of blinding is appropriate? | 0 |
|
Total score= | 3 |
1 = Yes; 0 = No.
Newcastle–Ottawa quality assessment scale for case-control studies.
| Newcastle–Ottawa Quality Assessment Scale Case-Control Studies | ||
|---|---|---|
| Author | Werkmeister 2005 [ | |
|
Is the case definition adequate? | * | |
|
Representativeness of the cases | * | |
|
Selection of Controls | * | |
|
Definition of Controls | * | |
|
Comparability of cases and controls on the basis of the design or analysis | * | |
|
Ascertainment of exposure | * | |
|
Same method of ascertainment for cases and controls | * | |
|
Non-Response rate | ||
| Total score= | 7 | |
* The tool is available or described.
Newcastle–Ottawa quality assessment scale for cohort studies.
| Newcastle–Ottawa Quality Assessment Scale Cohort Studies | |||||||
|---|---|---|---|---|---|---|---|
| Author | Adeyemo 2008 [ | Chiapasco 1995 [ | D’Angeli 2021 [ | Monaco 2016 [ | Cassetta 2017 [ | Zhang 2012 [ | |
|
Representativeness of the exposed cohort | * | * | * | * | * | * | |
|
Selection of the non-exposed cohort | * | * | |||||
|
Ascertainment of exposure | * | * | * | * | * | * | |
|
Demonstration that outcome of interest was not present at start of study | * | * | * | ||||
|
Comparability of cohorts on the basis of the design or analysis | * | * | * | * | |||
|
Assessment of outcome ** | * | ** | ** | ** | ** | * | |
|
Was follow-up long enough for outcomes to occur | * | * | * | * | |||
|
Adequacy of follow up of cohorts | * | * | * | ||||
| Total score = | 6 | 5 | 7 | 7 | 8 | 5 | |
* The tool is available or described; ** Validated measurement tool.